☰

NEOGENE

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of NEOGENE's published strategy and is not endorsed by, or produced in cooperation with, NEOGENE. Company website

Strategic priorities

NEOGENE operates across 4 stated priorities, with the most concrete near-term plan anchored on smart factory automation for cell therapy.

Transitioning the Santa Monica cGMP facility from manual, paper-based operations to a fully automated "Smart Factory" with integrated IT/OT systems, closed-loop bioreactor control, and real-time process monitoring to increase batch density without expanding physical footprint.

Establishing smooth digital handover between Dutch discovery research (TCR identification, genomic screening) and US translational manufacturing to eliminate data latency and transcription errors in the "bench-to-bedside" pipeline.

Developing adaptive manufacturing protocols and digital twins to normalize donor variability in patient-derived T-cells, reducing batch failure rates and enabling consistent yields across hundreds of individualized patient batches.

Challenges we see

  • Operations Manufacturing

    Donor Variability in Autologous Starting Material

    Every Neogene TCR-T product begins with a patient's own T-cells, which vary significantly based on age, health status, prior treatments, and individual biology. Current manufacturing protocols struggle to adapt to these inherent differences.

    Non-adaptive expansion processes lead to inconsistent yields and risk batch failures, with each failed batch representing total therapeutic loss for the individual patient and upwards of $400,000 in manufacturing costs.

  • Operations Supply Chain

    Vein-to-Vein Logistics and Cold Chain Integrity

    Autologous cell therapy requires a flawless chain of identity (COI) and chain of custody (COC). Fresh apheresis material must reach Santa Monica within 48 hours, and final product requires storage at -150°C in liquid nitrogen throughout distribution.

    Any disruption in the logistics chain—flight delays, customs issues, temperature excursions—results in complete therapeutic failure. Manual tracking and paper-based documentation create risks of identity errors and compliance gaps.

  • Digital Integration

    Joining records across systems

    TCR discovery in Amsterdam generates petabytes of genomic screening data that must be translated into specific CRISPR engineering protocols for Santa Monica manufacturing. These systems currently operate with limited interoperability.

    Data handover gaps and transcription errors extend the discovery-to-clinic timeline, creating bottlenecks that prevent Neogene from scaling patient enrollment in clinical trials.

  • Compliance Regulatory

    Manual Paper-Based Quality Control Workflows

    Despite advanced CRISPR science, the manufacturing facility relies heavily on manual, paper-based records for documenting manufacturing steps, quality control checks, and batch release decisions.

    Manual data entry is a primary source of regulatory risks and audit exposure. For individualized products requiring immutable audit trails for CRISPR off-target validation, paper workflows cannot meet FDA ALCOA+ data integrity requirements.

  • Digital Integration

    IT/OT Fragmentation in Bioreactor Systems

    Operational technology controlling bioreactors and expansion culture vessels operates in isolation from enterprise IT systems used for clinical trial management, ERP, and supply chain coordination.

    Disconnected systems block implementation of predictive analytics for equipment maintenance and process drift detection. Real-time optimization of T-cell expansion parameters is impossible without unified data infrastructure.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Adaptive Manufacturing for Donor Variability

    Patient-derived T-cells arrive at the Santa Monica facility with unpredictable characteristics. Current fixed manufacturing protocols cannot dynamically adjust to these variations, resulting in inconsistent expansion yields and batch failure rates that undermine clinical trial scalability.

    Deploy Digital Twin simulation technology to model T-cell expansion conditions based on incoming patient material characteristics, enabling predictive batch optimization and adaptive protocol selection before manufacturing begins.

  2. Unified Transatlantic Data Platform

    Genomic discoveries in Amsterdam cannot be smooth instantiated in Santa Monica manufacturing systems due to disconnected data architectures. This "data latency" extends the time from TCR identification to clinical treatment and increases transcription error risk.

    Implement an Industrial Data Platform with semantic mapping to serve as a "Single Source of Truth" bridging Dutch discovery research and US translational manufacturing, enabling automated protocol generation from validated TCR sequences.

  3. Automated Chain-of-Identity Tracking

    The 48-hour "vein-to-vein" window for autologous cell therapy requires flawless tracking of patient material identity and custody. Manual paper-based systems cannot provide the real-time visibility and immutable audit trail required for regulatory compliance.

    Deploy IoT-enabled tracking with blockchain-secured chain-of-identity records, providing real-time visibility into material location, temperature integrity, and custody transfers throughout the logistics chain.

  4. Smart Factory IT/OT Convergence

    Bioreactor OT systems and enterprise IT systems operate as isolated islands, preventing real-time process optimization, predictive maintenance, and closed-loop quality control in the manufacturing facility.

    Implement IT/OT convergence architecture connecting bioreactor controls, environmental monitoring, and enterprise systems through OPC UA standardization, enabling the "Smart Factory" vision articulated by SVP Technical Operations.

  5. Electronic Batch Records for CRISPR Compliance

    CRISPR gene-editing technology requires durable documentation of off-target effect validation for every individualized batch. Paper/Excel workflows cannot provide the automated, immutable audit trails required for FDA/EMA regulatory submissions.

    Transition to paperless digital systems with electronic batch records (EBR), automated data capture from instruments, and real-time compliance verification aligned with ALCOA+ data integrity principles.

What we'd propose

  • Enterprise AI

    Digital Twin for T-Cell Expansion Optimization

    Cloud-agnostic digital simulation platform that models patient-specific T-cell expansion conditions, enabling predictive batch optimization and adaptive protocol selection to normalize donor variability and reduce manufacturing failures.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Enterprise AI

    Industrial Data Platform for Transatlantic Integration

    Ontology-based data lakehouse that bridges Amsterdam discovery research systems with Santa Monica manufacturing execution, creating a unified "Single Source of Truth" for the TCR identification-to-treatment pipeline.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Digital Lab

    QC Lab Digital Transformation with Electronic Batch Records

    Comprehensive digitalization of quality control workflows replacing paper-based documentation with electronic batch records, automated data capture, and ALCOA+-compliant audit trails for CRISPR regulatory submissions.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    Smart Factory IT/OT Convergence Architecture

    Unified automation architecture connecting bioreactor operational technology with enterprise IT systems through OPC UA standardization, enabling real-time process optimization and predictive maintenance in the cGMP manufacturing facility.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital CDMO

    Blockchain-Enabled Chain-of-Identity Tracking

    IoT-enabled logistics tracking system with blockchain-secured chain-of-identity records, providing real-time visibility and immutable audit trails throughout the autologous "vein-to-vein" supply chain.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what NEOGENE's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Process Automation 30 → 90
Manual paper-based QC and bioreactor operations; "Smart Factory" vision articulated but not yet implemented
Data Integration 25 → 95
Genomic data silos between Amsterdam and Santa Monica; no unified platform for discovery-to-manufacturing handover
Predictive Analytics 20 → 85
Donor variability challenges addressed reactively; no Digital Twin capability for batch outcome prediction
Workforce Augmentation 35 → 80
SVP Technical Operations identifies "workforce readiness" as key challenge; manual processes dominate cleanroom operations
Supply Chain Digitalization 25 → 90
Paper-based chain-of-identity tracking; no real-time visibility into 48-hour "vein-to-vein" logistics
Regulatory Compliance 40 → 95
Paper/Excel workflows persist for CRISPR documentation; automated audit trails needed for FDA/EMA gene-editing requirements

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with NEOGENE, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].